BOSTON, May 8, 2024 – Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, today announced that Joanne Kotz, Ph.D., Co-founder and Chief Executive Officer, will present a corporate overview at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024 at 2:05 p.m. ET. … The post Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference appeared first on Jnana Therapeutics .